Futura Medical plc research, develops, and commercializes pharmaceutical and healthcare products for sexual health. The company's lead product includes Eroxon, a topical treatment for erectile dysfunction. It also develops WSD4000 for the treatment of sexual dysfunction in women. The company operates in the United Kingdom, the European Union, the United States, and internationally. Futura Medical plc was incorporated in 2001 and is headquartered in Guildford, the United Kingdom.
Frequently asked questions
What sector does Futura Medical plc (FAMDF) operate in?
Futura Medical plc belongs to the Healthcare sector and operates in the Biotechnology industry.
What is Futura Medical plc (FAMDF) current stock price?
As of the latest data, Futura Medical plc stock price is $0.00, with a previous close of $0.00.
What is Futura Medical plc (FAMDF) current market capitalization?
Futura Medical plc market cap is approximately 2.96 million.
What is Futura Medical plc (FAMDF) Earnings Per Share (EPS)?
The trailing EPS is -$0.01.
What is Futura Medical plc (FAMDF) EBITDA?
Futura Medical plc EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) is -1.25 million.
Does Futura Medical plc (FAMDF) pay dividends?
No. Futura Medical plc does not pay a dividend.
What is Futura Medical plc (FAMDF) beta (volatility) score?
Futura Medical plc has a beta of 0.141, indicating lower volatility than the overall market.